161 related articles for article (PubMed ID: 20025488)
1. Aggressive systemic mastocytosis with Charcot-Leyden crystals-associated crystal storing histiocytosis in bone marrow.
Alayed KM; Alabdulaali MK; Alkhairy KS; Elnour S; Alhajjaj A
Pathology; 2010 Jan; 42(1):85-7. PubMed ID: 20025488
[No Abstract] [Full Text] [Related]
2. Crystal-storing histiocytosis due to massive accumulation of charcot-leyden crystals: a unique association producing colonic polyposis in a 78-year-old woman with eosinophilic colitis.
Lewis JT; Candelora JN; Hogan RB; Briggs FR; Abraham SC
Am J Surg Pathol; 2007 Mar; 31(3):481-5. PubMed ID: 17325492
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis associated with acute myeloid leukaemia.
Fong C; Tong M
Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
[No Abstract] [Full Text] [Related]
4. The ultrastructural findings of Charcot-Leyden crystals in stroma of mastocytoma.
Lao LM; Kumakiri M; Nakagawa K; Ishida H; Ishiguro K; Yanagihara M; Ueda K
J Dermatol Sci; 1998 Jul; 17(3):198-204. PubMed ID: 9697048
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis.
Elliott MA; Pardanani A; Li CY; Tefferi A
Leukemia; 2004 May; 18(5):1027-9. PubMed ID: 15014525
[No Abstract] [Full Text] [Related]
6. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
[TBL] [Abstract][Full Text] [Related]
7. Indolent systemic mastocytosis.
Vano-Galvan S; De la Hoz B; Nuñez R; Jaen P
Isr Med Assoc J; 2010 Mar; 12(3):185-7. PubMed ID: 20684189
[No Abstract] [Full Text] [Related]
8. Identification of Charcot-Leyden crystals by electron microscopy.
Carson HJ; Buschmann RJ; Weisz-Carrington P; Choi YS
Ultrastruct Pathol; 1992; 16(4):403-11. PubMed ID: 1502737
[TBL] [Abstract][Full Text] [Related]
9. Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.
Radujkovic A; Bellos F; Andrulis M; Ho AD; Hundemer M
Eur J Haematol; 2011 May; 86(5):451-2. PubMed ID: 21342270
[No Abstract] [Full Text] [Related]
10. Anemia, leukocytosis, abdominal pain, flushing, and bone and skin lesions.
Álvarez-Twose I; Vañó-Galván S; Sanchez-Muñoz L; Fernandez-Zapardiel S; Escribano L
Cleve Clin J Med; 2012 Jun; 79(6):384-6. PubMed ID: 22660869
[No Abstract] [Full Text] [Related]
11. Systemic mastocytosis.
Bouvier S; Arnaud A
Blood; 2013 Feb; 121(7):1071. PubMed ID: 23536922
[No Abstract] [Full Text] [Related]
12. Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.
Golardi N; Sramek JE; Myers JB; Saffer H; George TI; Czuchlewski DR
Hum Pathol; 2014 Feb; 45(2):417-20. PubMed ID: 24182560
[TBL] [Abstract][Full Text] [Related]
13. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
14. Thumbprints in the ileum.
Mecklenburg I; Probst A; Messmann H
Gastroenterology; 2011 May; 140(5):1400, 1698. PubMed ID: 21440584
[No Abstract] [Full Text] [Related]
15. Use of octreotide for relief of gastro-intestinal (GI) symptoms in systemic mastocytosis.
Sadashiv S; Bower K; Sahovic E; Bunker M; Christou A
Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):72-5. PubMed ID: 23712217
[No Abstract] [Full Text] [Related]
16. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
17. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
Falleti J; Borgia L; Lalinga AV; De Cecio R; Natella V; Patitucci G; Vita G
Pathol Res Pract; 2012 Nov; 208(11):683-6. PubMed ID: 22963840
[TBL] [Abstract][Full Text] [Related]
18. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia with bone marrow necrosis and Charcot Leyden crystals.
Vermeersch P; Zachee P; Brusselmans C
Am J Hematol; 2007 Nov; 82(11):1029. PubMed ID: 17617789
[No Abstract] [Full Text] [Related]
20. A Brief History of Charcot-Leyden Crystal Protein/Galectin-10 Research.
Su J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30424011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
